Abeona Therapeutics (ABEO) EBITDA Margin Growth (3y) (2014 - 2025)

Abeona Therapeutics (ABEO) EBITDA Margin Growth (3y) (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,942.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Abeona Therapeutics 107.85 Mn -60.42 Mn 6.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.86 Mn
Jun 30, 2025 -489,720.00
Dec 31, 2020 1.30 Mn
Sep 30, 2020 346,174.00
Dec 31, 2018 -197,239.00
Sep 30, 2018 116,008.00
Jun 30, 2018 -338,479.00
Mar 31, 2018 -144,503.00
Dec 31, 2017 -1.36 Mn
Sep 30, 2017 -279,742.00
Jun 30, 2017 -1.19 Mn
Mar 31, 2017 -1.45 Mn
Dec 31, 2016 298,341.00
Sep 30, 2016 -1.53 Mn
Jun 30, 2016 -1.01 Mn
Mar 31, 2016 -729,005.00
Dec 31, 2015 -279,206.00
Sep 30, 2015 -204,040.00
Jun 30, 2015 -125,954.00
Mar 31, 2015 -65,656.00